Introduction
Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease, usually occurring in the elderly, which is characterized by large, tense blisters. The production of autoantibodies directed to a 180-kDa hemidesmosomal protein (BP180) of the basement membrane zone is the initiating event of the pathomechanisms 1 . Once the autoantibodies bind to the basement membrane, a cascade of inflammatory events occurs, resulting in a subsequent blister formation at the dermo-epidermal junction.
During this process, cytokines and chemokines are considered to play crucial roles in inflammatory cell recruitment, deposition, and perpetuation 2 . Therefore, clarifying the serum and local levels of cytokines and chemokines may help to understand the immune dysregulation in the pathomechanism.
It has been demonstrated that various cytokines including interleukin (IL)-1β, IL-2, IL-4, IL-5, IL-6, IL-8, interferon (IFN)-γ, and tumour necrosis factor
(TNF)-α increased in sera of BP patients [3] [4] [5] [6] [7] [8] . By contrast, while serum levels of several chemokines including eotaxin [9] [10] [11] , "regulated upon activation, normal T-cell expressed and presumably secreted" (RANTES) 6 , thymus and activation-regulated chemokine (TARC) 12 , and mucosae-associated epithelial chemokine (MEC) 13 have been reported, the involvement of most chemokines in the disease remains unknown. In this study, we utilized a recently developed protein array system and assessed the serum levels of 10 chemokines: IFN-γ-inducible protein-10 (IP-10), monokine induced by IFN-γ (MIG), macrophage inflammatory protein (MIP)-1α, MIP-1β, monocyte chemoattractant protein (MCP)-1, MCP-2, MCP-3, and growth-regulated oncogene-α (GRO-α), in addition to eotaxin and RANTES.
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Materials and methods

Subjects.
Multiplex chemokine assay.
Ten chemokines simultaneously measured included IP-10, MIG, MIP-1α, MIP-1β, RANTES, eotaxin, MCP-1, MCP-2, MCP-3 and GRO-α. A sandwich immunoassay-based protein array system (Biosource, Camarillo, CA, USA), which contains dyed microspheres conjugated with a monoclonal antibody specific for a target protein, was used. Serum samples were thawed and run in duplicates. Antibody-coupled beads were incubated with the plasma sample after which they were incubated with biotinylated detection antibody before finally being incubated with streptavidin-conjugated phycoerythrin. A broad sensitivity range of standards (Biosource) ranging from 1.95 to 32,000 pg/ml were used for the quantitation of a 
Statistical analysis.
Statistical differences between measured values of BP patients, those of PV patients, and those of controls were analyzed using Steel-Dwass' multiple comparison test. Trends in the measured values according to the affected area (disease severity)
were analyzed by the two-sided Jonckheere-Terpstra test. Correlations between each serum chemokine level were analyzed using with Spearman's correlation coefficient by rank test. P values less than 0.05 were considered statistically significant.
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Results
Serum levels of ten chemokines in BP and PV patients
Concentrations of ten chemokines, IP-10, MIG, MIP-1α, MIP-1β, RANTES, eotaxin, MCP-1, MCP-2, MCP-3 and GRO-α were simultaneously measured in the sera from BP patients, PV patients, and healthy controls. Serum levels of IP-10 and MCP-1 were significantly increased in BP patients compared with healthy controls (p = 0.011 for IP-10 and p = 0.014 for MCP-1, Fig. 1 ). Serum levels of MIG, MIP-1α, MIP-1β, and eotaxin were also slightly higher in BP patients than in controls, although the differences were not significant. By contrast, all chemokines except for eotaxin showed comparable levels between PV patients and healthy controls (Fig. 1 ). Serum eotaxin levels in PV patients were higher than those in controls although the difference was not significant (Fig. 1) .
When each chemokine level higher than the mean + 2SD of the control serum samples were considered to be elevated, IP-10 level was elevated in 39%, MIG in 29%, MIP-1α in 18%, MIP-1β in 29%, eotaxin in 32% and MCP-1 in 36% of BP patients (Table 1) . In PV patients, 36% had elevated eotaxin level, 24% had elevated MCP-1 level, and 18% had elevated IP-10 level. While increased RANTES level was observed in one control sample, all the other chemokine levels in control samples were less than the mean + 2SD levels. Collectively, BP patients showed more prominent abnormalities in chemokine levels than PV patients.
Positive correlation between serum levels of MIG and MCP-1 and the severity.
To assess the association of chemokine levels with disease severity, BP patients were classified into three groups by their affected % areas of the body surface. (Fig. 2) . By contrast, serum levels of MIP-1α, MIP-1β, MCP-2, MCP-3, GRO-α, or RANTES showed no such tendency (data not shown). Thus, serum levels of MIG, IP-10, MCP-1, and eotaxin appear to reflect the disease severity.
Correlation between serum chemokine levels
We further analyzed the correlation between serum levels of measured BP lesions exhibit prominent eosinophil infiltration. Eotaxin is considered to be a potent chemoattractant and activator of eosinophils 19 , and main attractant of Th2 lymphocytes 20, 21 . Although serum eotaxin levels were not significantly increased in total BP patients, serum eotaxin levels were associated with disease severity and also positively correlated with IP-10 and MCP-1. Correlation between eotaxin and these chemokines implies that there may be a similar process for infiltrations of eosinophils and another subset of leukocytes including Th1 lymphocytes. Some previous reports have demonstrated elevated levels of eotaxin in sera and blister fluid as well as increased expression in the skin lesion of BP patients [9] [10] [11] . The enhanced expression of eotaxin indicates that this chemokine may also play an important role in the pathomechanism of this autoimmune bullous skin disease by recruiting and activating eosinophils and lymphocytes.
MCP-1 is a chemoattractant and activator of monocytes, lymphocytes, and basophils, but lacks activity on neutrophils and eosinophils 22, 23 . Serum MCP-1 levels in BP patients were elevated, exhibiting a tendency to increase according to the disease In summary, the current study indicates that BP patients have a complex disorder of various chemokine levels in their sera. This supports that various immune pathways are involved in the pathogenesis of BP. It was also remarkable that the chemokine profile of the sera from BP patients showed heterogeneity, which may suggest that the different profile correspond to distinct disease subset or severity, or may reflect different stage of the disease. Nonetheless, it appears that especially MCP-1 and IP-10, then MIG and eotaxin, play relatively important roles than the other chemokines in BP. Further profiling of immune mediators including chemokines will elucidate the precise mechanism of the disease development.
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